The use of insulin glargine with gestational diabetes mellitus [14]

Diabetes Care

Volumn 29, Issue 2, 2006, Pages 471-472

  Graves, Darby E ^a,b   White, Jenifer C ^b   Kirk, Julienne K ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN GLARGINE; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLARGINE; INSULIN;

BLOOD GLUCOSE MONITORING; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; MATERNAL WELFARE; NEWBORN CARE; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; TREATMENT OUTCOME; FEMALE; NOTE;

DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PREGNANCY; PREGNANCY OUTCOME;

EID: 33646339424     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.29.02.06.dc05-2042     Document Type: Letter

References (5)

1. Woolderink JM, van Loon AJ, Storms F, de Heide L, Hoogenberg K: Use of insulin glargine during pregnancy in seven type 1 diabetic women (Letter). Diabetes Care 28:2594-2595, 2005
2. American College of Obstetricians and Gynecologists Committee on Practice Bulletins, Obstetrics: ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists: No. 30, September 2001 (replaces technical bulletin no. 200, December 1994). Gestational diabetes. Obstet Gynecol 98:525-538, 2001
3. American Diabetes Association: Gestational diabetes mellitus (Position Statement). Diabetes Care 27 (Suppl. 1):S88-S90, 2004
4. Thompson DM, Dansereau J, Creed M, Ridell L: Tight glucose control results in normal perinatal outcome in 150 patients with gestational diabetes. Obstet Gynecol 83:362-366, 1994
5. Langer O, Yogev Y, Most O, Xenakis E: Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 192: 989-997, 2005